Number 38

Improvement of the Walking Ability in Intermittent Claudification with Supervised Exercise and Pneumatic Foot and Calf Compression: Results at Six Months of a Randomized Controlled Trial

S Kakkos, G Geroulakos, A Nicolaides. 

Vascular Unit, Ealing Hospital and Department of Vascular Surgery Imperial College, London, UK.  Presented at the 2004 European Society for Vascular Surgery Annual Meeting.

Introduction/Aim of the Study:  The purpose of the prospective randomized trial is to compare the effect of unsupervised exercise, supervised exercise and intermittent pneumatic foot and calf compression (IPC) on the claudication distance and lower limb arterial hemodynamics of patients with intermittent claudication as a result of superficial femoral artery occlusion.

Materials/Methods:  Thirty-four eligible patients with stable intermittent claudication and absolute claudication distance (ACD) 300m, selected out of 151 patients screened, were randomized to IPC (ArtAssist® device, model AA-1000, n=13, for 3 hr/d), supervised exercise (n=12, three hour session/week on a treadmill in the physiotherapy department) or unsupervised exercise (n=9), with stratification for age and walking distance.  All patients were on antiplatelet agents and were asked to exercise daily by walking.  In each patient, initial claudication distance (ICD), ACD, resting ankle brachial pressure index (ABPI) resting and reactive hyperemic calf arterial inflow (15 serial measurements, 15 seconds apart, following 5 minutes of thigh occlusion) were measured before, and six weeks and six months after randomization, using venous occlusion air plethysmography (APG).  Reactive hyperemic calf arterial inflow was normalized for resting flow, while the hyperemic index (ratio of the area under the hyperemic curve/peak flow) was also calculated.  All results are shown as median and interquartile range. 

Results:  Compared with unsupervised exercise, both IPC and supervised exercise increased ICD and ACD, up to 2.6 times (Table).  IPC increased arterial inflow (p<0.05 at 6 weeks) and ABPI, and decreased the reactive hyperemic flow ratio at 15 seconds (at week 6, p<0.009) and 30 seconds (at week 6, p<0.01 and month 6, p<0.028).  Supervised exercise decreased arterial inflow and increased ABPI (p<0.05 at 6 months).  Unsupervised exercise had no effect on arterial inflow or ABPI.   

Group

Baseline

6 weeks

6 month

ICD (m)

Unsupervised Exercise

70 (22.5)

80 (45)

77.5 (17.5)

Supervised Exercise

60 (26.25)

80 (35)*

70 (45)*

IPC

60 (35)

85 (65)*

90 (85)

ACD (m)

Unsupervised Exercise

135 (87.5)

130 (130)

130 (62.5)

Supervised Exercise

145 (108.75)

235 (142.5)**

220 (282.5)*

IPC

145 (145)

295 (210)**

370 (732.5)*

ABPI

Unsupervised Exercise

.060 (0.24)

0.60 (0.20)

0.60 (0.13)

Supervised Exercise

0.51 (0.14)

0.56 (0.21)

0.62 (0.15)*

IPC

0.56 (0.16)

0.60 (0.08)

0.62 (.034

Resting Arterial Inflow (ml/sec)

Unsupervised Exercise

1024 (0.81)

1.24 (1.13)

1.28 (0.94)

Supervised Exercise

108 (0.80)

1.32 (1.38)

1.26 (0.64)

IPC

0.9 (0.59)

1.15 (1.04)*

1.04 (0.39)

Hyperemic Index

Unsupervised Exercise

2.05 (1.40)

1.97 (1.59)

2.73 (1.75)

Supervised Exercise

2.26 (2.94)

2.37 (2.59)

2.67 (2.56)

IPC

3.14 (1.27)

1.93 (3.00)

1.99 (2.38)

Intra-group

Comparison

*p<0.05

**p<0.01

Conclusion:  IPC, by augmenting leg perfusion, achieved improvement in walking distance comparable with supervised exercise.  No improvement or perfusion changes were seen in patients randomized to unsupervised exercise.  Long-term results in a larger number of patients will provide valuable information on the optimal treatment modality of intermittent claudication.

 

 

Return to Abstract Menu

NEXT

ArtAssist®, VenAssist®, VenaPulse®, and APG® are register trademarks of ACI Medical, Inc., San Marcos, CA, USA.